<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phgenomics</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакогенетика и фармакогеномика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacogenetics and Pharmacogenomics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2588-0527</issn><issn pub-type="epub">2686-8849</issn><publisher><publisher-name>LLC "Izdatelstvo OKI"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2588-0527-2021-1-9-17</article-id><article-id custom-type="elpub" pub-id-type="custom">phgenomics-218</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CURRENT REVIEW</subject></subj-group></article-categories><title-group><article-title>Полиморфизм гена ADRB2 и состояние угрозы преждевременных родов</article-title><trans-title-group xml:lang="en"><trans-title>ADRB2 gene polymorphism and preterm labor</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0802-4229</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Казаков</surname><given-names>Р. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Kazakov</surname><given-names>R. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Казаков Руслан Евгеньевич, к. б. н., начальник отдела персонализированной медицины и клинической фармакогенетики</p><p>Москва</p></bio><bio xml:lang="en"><p>Kazakov Ruslan Ye., Cand. Sci. (Biol.), Head of the Department of Personalized Medicine and Clinical Pharmacogenetics CCP</p><p>Moscow</p></bio><email xlink:type="simple">rustic100@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6331-3109</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чилова</surname><given-names>Р. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chilova</surname><given-names>R. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чилова Раиса Алексеевна, д. м. н., доцент, профессор кафедры акушерства и гинекологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Chilova Raisa A., Dr. Sci. (Med.), Associate Professor, Professor of the Department of Obstetrics and Gynecology</p><p>Moscow</p></bio><email xlink:type="simple">rtchilova@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3268-481X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акопов</surname><given-names>К. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Akopov</surname><given-names>K. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Акопов Константин Олегович, врач акушер-гинеколог</p><p>Москва</p></bio><bio xml:lang="en"><p>Akopov Konstantin O., doctor obstetrician-gynecologist</p><p>Moscow</p></bio><email xlink:type="simple">akopovkonstantin@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6389-2099</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сокова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sokova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сокова Елена Андреевна, к. м. н., доцент; ведущий аналитик</p><p>Москва</p></bio><bio xml:lang="en"><p>Sokova Elena A., Cand. Sci. (Med.), Associate Professor; lead analyst CCP</p><p>Moscow</p></bio><email xlink:type="simple">rtchilova@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НЦЭСМП» Минздрава России; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBI «SCEEMP» of the Ministry of Health of the Russian Federation; Russian Medical Academy of Continuing Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый МГМУ им. И.М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuing Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Государственное бюджетное учреждение здравоохранения города Москвы «Городская клиническая больница имени С.С. Юдина Департамента здравоохранения города Москвы» ДЗМ ЖК № 3</institution><country>Россия</country></aff><aff xml:lang="en"><institution>S.S. Yudin State Clinical Hospital of the Moscow Department of Health Care» women’s consultation No. 3</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБУ «НЦЭСМП» Минздрава России; ФГАОУ ВО Первый МГМУ им. И.М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBI «SCEEMP» of the Ministry of Health of the Russian Federation; Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>07</day><month>01</month><year>2022</year></pub-date><volume>0</volume><issue>1</issue><fpage>9</fpage><lpage>17</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Казаков Р.Е., Чилова Р.А., Акопов К.О., Сокова Е.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Казаков Р.Е., Чилова Р.А., Акопов К.О., Сокова Е.А.</copyright-holder><copyright-holder xml:lang="en">Kazakov R.E., Chilova R.A., Akopov K.O., Sokova E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/218">https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/218</self-uri><abstract><p>В данной статье обсуждаются вопросы, связанные с ролью полиморфизма гена ADRB2, кодирующего β2-адренорецептор, при преждевременных родах и токолизе. Приводится информация о научных исследованиях по поиску ассоциаций носительства аллелей и генотипов ADRB2 с состоянием угрозы преждевременных родов, с самопроизвольными преждевременными родами, а также с фармакологическим ответом на токолитическую терапию с помощью β2-адреномиметиков. В хронологическом порядке изложена история открытия взаимосвязи полиморфизма гена ADRB2 с преждевременными родами. По мере появления научных фактов, перед исследователями возникает вопрос: каким образом полиморфизмы гена ADRB2 могут отражаться на физиологических процессах? То есть, влияют ли они посредством изменения первичной структуры рецептора или же посредством изменения уровня экспрессии. В зависимости от ответа на этот вопрос перед фармакогенетиками ставится дальнейшая задача: что изучать – отдельные полиморфизмы или гаплотипы?</p></abstract><trans-abstract xml:lang="en"><p>This article discusses issues related to the role of polymorphism of the ADRB2 gene encoding β2-adrenergic receptor in preterm labor and tocolysis. Information is provided on scientific studies related to the search for associations of the carriage of alleles and genotypes of ADRB2 with the preterm labor, as well as with the pharmacological response to tocolytic therapy using β2-adrenergic agonists. The history of the discovery of the relationship of ADRB2 gene polymorphisms with preterm labor is presented in chronological order. As scientific facts emerge, researchers are faced with the question: how can ADRB2 gene polymorphisms affect physiological processes? That is, whether they affect by changing the primary structure of the receptor or by changing the level of expression. Depending on the answer to this question, pharmacogenetics are faced with a further task: what to study - individual polymorphisms or haplotypes?</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фармакогенетика</kwd><kwd>однонуклеотидный полиморфизм</kwd><kwd>ADRB2</kwd><kwd>β2-адренорецепторы</kwd><kwd>токолиз</kwd><kwd>гексопреналин</kwd><kwd>преждевременные роды</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pharmacogenetics</kwd><kwd>therapeutic drug monitoring</kwd><kwd>genetic biomarkers</kwd><kwd>statins</kwd><kwd>simvastatin</kwd><kwd>atorvastatin</kwd><kwd>single nucleotide polymorphisms</kwd><kwd>SLCO1B1</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Blencowe H, Krasevec J, de Onis M et al. National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis. Lancet Glob Health. 2019 Jul;7(7):e849-e860. DOI: 10.1016/S2214-109X(18)30565-5.</mixed-citation><mixed-citation xml:lang="en">Blencowe H, Krasevec J, de Onis M et al. National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis. Lancet Glob Health. 2019 Jul;7(7):e849-e860. DOI: 10.1016/S2214-109X(18)30565-5.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sheikh IA, Ahmad E, Jamal MS et al. Spontaneous preterm birth and single nucleotide gene polymorphisms: a recent update. BMC Genomics. 2016;17(Suppl 9):759. DOI: 10.1186/s12864-016-3089-0.</mixed-citation><mixed-citation xml:lang="en">Sheikh IA, Ahmad E, Jamal MS et al. Spontaneous preterm birth and single nucleotide gene polymorphisms: a recent update. BMC Genomics. 2016;17(Suppl 9):759. DOI: 10.1186/s12864-016-3089-0.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008 Jan 5;371(9606):75–84. DOI: 10.1016/S0140-6736(08)60074-4.</mixed-citation><mixed-citation xml:lang="en">Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008 Jan 5;371(9606):75–84. DOI: 10.1016/S0140-6736(08)60074-4.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Crider KS, Whitehead N, Buus RM. Genetic variation associated with preterm birth: A HuGE. Genet Med. 2005 Nov-Dec;7(9):593–604. DOI: 10.1097/01.gim.0000187223.69947.db.</mixed-citation><mixed-citation xml:lang="en">Crider KS, Whitehead N, Buus RM. Genetic variation associated with preterm birth: A HuGE. Genet Med. 2005 Nov-Dec;7(9):593–604. DOI: 10.1097/01.gim.0000187223.69947.db.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ip M, Peyman E, Lohsoonthorn V et al. A Case-Control Study of Preterm Delivery Risk Factors According to Clinical Subtypes and Severity. J Obstet Gynaecol Res. 2010 February; 36(1):34–44. DOI:10.1111/ j.1447-0756.2009.01087.x.</mixed-citation><mixed-citation xml:lang="en">Ip M, Peyman E, Lohsoonthorn V et al. A Case-Control Study of Preterm Delivery Risk Factors According to Clinical Subtypes and Severity. J Obstet Gynaecol Res. 2010 February; 36(1):34–44. DOI:10.1111/ j.1447-0756.2009.01087.x.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Varner MW, Esplin MS. Current understanding of genetic factors in preterm birth. BJOG. 2005 Mar;112 Suppl 1:28–31. DOI: 10.1111/ j.1471-0528.2005.00581.x.</mixed-citation><mixed-citation xml:lang="en">Varner MW, Esplin MS. Current understanding of genetic factors in preterm birth. BJOG. 2005 Mar;112 Suppl 1:28–31. DOI: 10.1111/ j.1471-0528.2005.00581.x.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Plunkett J, Muglia LJ. Genetic contributions to preterm birth: implications from epidemiological and genetic association studies. Ann Med. 2008;40(3):167–195. DOI: 10.1080/07853890701806181.</mixed-citation><mixed-citation xml:lang="en">Plunkett J, Muglia LJ. Genetic contributions to preterm birth: implications from epidemiological and genetic association studies. Ann Med. 2008;40(3):167–195. DOI: 10.1080/07853890701806181.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Plunkett J, Borecki I, Morgan T, Stamilio D, Muglia LJ. Populationbased estimate of sibling risk for preterm birth, preterm premature rupture of membranes, placental abruption and pre-eclampsia. BMC Genet. 2008;9:44. DOI: 10.1186/1471-2156-9-44.</mixed-citation><mixed-citation xml:lang="en">Plunkett J, Borecki I, Morgan T, Stamilio D, Muglia LJ. Populationbased estimate of sibling risk for preterm birth, preterm premature rupture of membranes, placental abruption and pre-eclampsia. BMC Genet. 2008;9:44. DOI: 10.1186/1471-2156-9-44.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberg CR, Shi M. The genetics of preterm birth: using what we know to design better association studies. Am J Epidemiol. 2009;170(11):1373–1381. DOI: 10.1093/aje/kwp325.</mixed-citation><mixed-citation xml:lang="en">Weinberg CR, Shi M. The genetics of preterm birth: using what we know to design better association studies. Am J Epidemiol. 2009;170(11):1373–1381. DOI: 10.1093/aje/kwp325.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Treloar SA, Macones GA, Mitchell LE, Martin NG. Genetic influences on premature parturition in an Australian twin sample. Twin Res. 2000;3(2): 80–82. DOI: 10.1375/136905200320565526.</mixed-citation><mixed-citation xml:lang="en">Treloar SA, Macones GA, Mitchell LE, Martin NG. Genetic influences on premature parturition in an Australian twin sample. Twin Res. 2000;3(2): 80–82. DOI: 10.1375/136905200320565526.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">York TP, Eaves LJ, Lichtenstein P et al. Fetal and maternal genes’ influence on gestational age in a quantitative genetic analysis of 244,000 Swedish births. Am J Epidemiol. 2013 Aug 15;178(4):543–550. DOI: 10.1093/aje/kwt005.</mixed-citation><mixed-citation xml:lang="en">York TP, Eaves LJ, Lichtenstein P et al. Fetal and maternal genes’ influence on gestational age in a quantitative genetic analysis of 244,000 Swedish births. Am J Epidemiol. 2013 Aug 15;178(4):543–550. DOI: 10.1093/aje/kwt005.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang G, Feenstra B, Bacelis J et al. Genetic Associations with Gestational Duration and Spontaneous Preterm Birth. N Engl J Med. 2017;377(12):1156–1167. DOI: 10.1056/NEJMoa1612665.</mixed-citation><mixed-citation xml:lang="en">Zhang G, Feenstra B, Bacelis J et al. Genetic Associations with Gestational Duration and Spontaneous Preterm Birth. N Engl J Med. 2017;377(12):1156–1167. DOI: 10.1056/NEJMoa1612665.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Савельева О.Н., Карунас А.С., Федорова Ю.Ю., Хуснутдинова Э.К. Роль полиморфных вариантов гена β2-адренергического рецептора (ADRB2) в развитии и течении бронхиальной астмы. Медицинский вестник Башкортостана. 2018;13(5(77)):69–75.</mixed-citation><mixed-citation xml:lang="en">Savelieva ON, Karunas AS, Fedorova YuYu, Khusnutdinova EK. The role of β2-adrenergic receptor gene (ADRB2) polymorphisms in asthma. Meditsinskiy vestnik Bashkortostana. 2018;13(5(77)):69–75. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hopes E, McDougall C, Christie G et al. Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study. BMJ. 1998 Feb 28;316(7132):664. DOI: 10.1136/bmj.316.7132.664.</mixed-citation><mixed-citation xml:lang="en">Hopes E, McDougall C, Christie G et al. Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study. BMJ. 1998 Feb 28;316(7132):664. DOI: 10.1136/bmj.316.7132.664.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ishiyama-Shigemoto S, Yamada K et al. Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia. 1999; 42(1):98–101. DOI: 10.1007/s001250051120.</mixed-citation><mixed-citation xml:lang="en">Ishiyama-Shigemoto S, Yamada K et al. Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia. 1999; 42(1):98–101. DOI: 10.1007/s001250051120.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bray MS, Krushkal J, Li L et al. Positional genomic analysis identifies the β2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation. 2000 Jun 27;101(25):2877–2882. DOI: 10.1161/01.cir.101.25.2877.</mixed-citation><mixed-citation xml:lang="en">Bray MS, Krushkal J, Li L et al. Positional genomic analysis identifies the β2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation. 2000 Jun 27;101(25):2877–2882. DOI: 10.1161/01.cir.101.25.2877.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cagliani R, Fumagalli M, Pozzoli U et al. Diverse evolutionary histories for beta-adrenoreceptor genes in humans. Am J Hum Genet. 2009;85(1):64–75. DOI: 10.1016/j.ajhg.2009.06.005.</mixed-citation><mixed-citation xml:lang="en">Cagliani R, Fumagalli M, Pozzoli U et al. Diverse evolutionary histories for beta-adrenoreceptor genes in humans. Am J Hum Genet. 2009;85(1):64–75. DOI: 10.1016/j.ajhg.2009.06.005.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Dishy V, Sofowora GG, Xie HG et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med. 2001; 345(14):1030–1035. DOI: 10.1056/NEJMoa010819.</mixed-citation><mixed-citation xml:lang="en">Dishy V, Sofowora GG, Xie HG et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med. 2001; 345(14):1030–1035. DOI: 10.1056/NEJMoa010819.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Landau R, Xie HG, Dishy V et al. Beta2-Adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol. 2002 Nov;187(5):1294–1298. DOI: 10.1067/mob.2002.128524.PMID: 12439523.</mixed-citation><mixed-citation xml:lang="en">Landau R, Xie HG, Dishy V et al. Beta2-Adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol. 2002 Nov;187(5):1294–1298. DOI: 10.1067/mob.2002.128524.PMID: 12439523.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Drysdale CM, McGraw DW, Stack CB et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10483–10488. DOI: 10.1073/pnas.97.19.10483.</mixed-citation><mixed-citation xml:lang="en">Drysdale CM, McGraw DW, Stack CB et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10483–10488. DOI: 10.1073/pnas.97.19.10483.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ratge D, Wiedemann A, Kohse KP, Wisser H. Alterations of betaadrenoceptors on human leukocyte subsets induced by dynamic exercise: effect of prednisone. Clin Exp Pharmacol Physiol. 1988;15(1):43–53. DOI: 10.1111/j.1440-1681.1988.tb01007.x.</mixed-citation><mixed-citation xml:lang="en">Ratge D, Wiedemann A, Kohse KP, Wisser H. Alterations of betaadrenoceptors on human leukocyte subsets induced by dynamic exercise: effect of prednisone. Clin Exp Pharmacol Physiol. 1988;15(1):43–53. DOI: 10.1111/j.1440-1681.1988.tb01007.x.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Murray DR, Irwin M, Rearden CA et al. Sympathetic and immune interactions during dynamic exercise. Mediation via a beta2-adrenergicdependent mechanism. Circulation. 1992; 86(1):203–213. DOI: 10.1161/01.cir.86.1.203.</mixed-citation><mixed-citation xml:lang="en">Murray DR, Irwin M, Rearden CA et al. Sympathetic and immune interactions during dynamic exercise. Mediation via a beta2-adrenergicdependent mechanism. Circulation. 1992; 86(1):203–213. DOI: 10.1161/01.cir.86.1.203.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Panebra A, Wang WC, Malone MM et al. Common ADRB2 haplotypes derived from 26 polymorphic sites direct beta2-adrenergic receptor expression and regulation phenotypes. PLoS One. 2010;5(7): e11819. DOI: 10.1371/journal.pone.0011819.</mixed-citation><mixed-citation xml:lang="en">Panebra A, Wang WC, Malone MM et al. Common ADRB2 haplotypes derived from 26 polymorphic sites direct beta2-adrenergic receptor expression and regulation phenotypes. PLoS One. 2010;5(7): e11819. DOI: 10.1371/journal.pone.0011819.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ozkur M, Dogulu F, Ozkur A et al. Association of the Gln27Glu polymorphism of the beta-2-adrenergic receptor with preterm labor. Int J Gynaecol Obstet. 2002;77(3):209–215. DOI: 10.1016/s0020-7292(02)00035-8.</mixed-citation><mixed-citation xml:lang="en">Ozkur M, Dogulu F, Ozkur A et al. Association of the Gln27Glu polymorphism of the beta-2-adrenergic receptor with preterm labor. Int J Gynaecol Obstet. 2002;77(3):209–215. DOI: 10.1016/s0020-7292(02)00035-8.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Doh K, Sziller I, Vardhana S. Beta2-adrenergic receptor gene polymorphisms and pregnancy outcome. J Perinat Med. 2004;32(5):413–417. DOI: 10.1515/JPM.2004.138.</mixed-citation><mixed-citation xml:lang="en">Doh K, Sziller I, Vardhana S. Beta2-adrenergic receptor gene polymorphisms and pregnancy outcome. J Perinat Med. 2004;32(5):413–417. DOI: 10.1515/JPM.2004.138.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lima JJ, Thomason DB, Mohamed MH et al. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther. 1999; 65(5):519–525. DOI: 10.1016/S0009-9236(99)70071-8.</mixed-citation><mixed-citation xml:lang="en">Lima JJ, Thomason DB, Mohamed MH et al. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther. 1999; 65(5):519–525. DOI: 10.1016/S0009-9236(99)70071-8.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Landau R, Morales MA, Antonarakis SE et al. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor. Clin Pharmacol Ther. 2005;78(6):656–663. DOI: 10.1016/j.clpt.2005.08.021.</mixed-citation><mixed-citation xml:lang="en">Landau R, Morales MA, Antonarakis SE et al. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor. Clin Pharmacol Ther. 2005;78(6):656–663. DOI: 10.1016/j.clpt.2005.08.021.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Gibson CS, maclennan AH, Dekker GA et al. Genetic polymorphisms and spontaneous preterm birth. Obstet Gynecol. 2007 Feb;109(2 Pt 1):384–391. DOI: 10.1097/01.AOG.0000252712.62241.1a.</mixed-citation><mixed-citation xml:lang="en">Gibson CS, maclennan AH, Dekker GA et al. Genetic polymorphisms and spontaneous preterm birth. Obstet Gynecol. 2007 Feb;109(2 Pt 1):384–391. DOI: 10.1097/01.AOG.0000252712.62241.1a.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ríos JC, McEwen JG, Cuartas A et al. Evaluación del efecto de cuatro polimorfismos en el gen del receptor adrenérgico β2 en el parto pretérmino. Colomb Med. 2008;39:7-15. [Ríos JC, McEwen JG, Cuartas A et al. Role of four polymorphisms of the β-2 adrenergic receptor gen in patients with preterm delivery. Colomb Med. 2008;39:7–15. (In Spanish).].</mixed-citation><mixed-citation xml:lang="en">Ríos JC, McEwen JG, Cuartas A et al. Evaluación del efecto de cuatro polimorfismos en el gen del receptor adrenérgico β2 en el parto pretérmino. Colomb Med. 2008;39:7-15. [Ríos JC, McEwen JG, Cuartas A et al. Role of four polymorphisms of the β-2 adrenergic receptor gen in patients with preterm delivery. Colomb Med. 2008;39:7–15. (In Spanish).].</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Miller RS, Smiley RM, Daniel D et al. Beta-2 adrenoceptor genotype and progress in term and late preterm active labor. Am J Obstet Gynecol. 2011;205(2):137.e1–7. DOI: 10.1016/j.ajog.2011.03.045.</mixed-citation><mixed-citation xml:lang="en">Miller RS, Smiley RM, Daniel D et al. Beta-2 adrenoceptor genotype and progress in term and late preterm active labor. Am J Obstet Gynecol. 2011;205(2):137.e1–7. DOI: 10.1016/j.ajog.2011.03.045.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Park YJ, Lee NR, Lee KE et al. Effects of β2-Adrenergic Receptor Gene Polymorphisms on Ritodrine Therapy in Pregnant Women with Preterm Labor: Prospective Follow-Up Study. Int J Mol Sci. 2014. 21;15(7):12885–12894. DOI: 10.3390/ijms150712885.</mixed-citation><mixed-citation xml:lang="en">Park YJ, Lee NR, Lee KE et al. Effects of β2-Adrenergic Receptor Gene Polymorphisms on Ritodrine Therapy in Pregnant Women with Preterm Labor: Prospective Follow-Up Study. Int J Mol Sci. 2014. 21;15(7):12885–12894. DOI: 10.3390/ijms150712885.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Chung JE, Choi SA, Hwang HS et al. Association between β2- adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study. BMC Genet. 2017 Nov 13;18(1):96. DOI: 10.1186/s12863-017-0565-8.</mixed-citation><mixed-citation xml:lang="en">Chung JE, Choi SA, Hwang HS et al. Association between β2- adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study. BMC Genet. 2017 Nov 13;18(1):96. DOI: 10.1186/s12863-017-0565-8.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Сухих Г.Т., Ходжаева З.С., Донников А.Е. и др. Молекулярно-генетические предикторы эффективности токолитической терапии в пролонгировании беременности при угрожающих преждевременных родах. Акушерство и гинекология. 2014;2:27–34.</mixed-citation><mixed-citation xml:lang="en">Sukhikh GT, Khodzhaeva ZS, Donnikov AE et al. Molecular genetic predictors of the efficiency of tocolytic therapy in pregnancy prolongation in threatened preterm labor. Obstetrics and gynecology. 2014;2:27–34. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Проклова Г.Ф., Сокова Е.А., Казаков Р.Е., Чилова Р.А., Жукова Э.В., Акопов К.О. Полиморфизм гена ADRB2 как предиктор преждевременных родов. Вопросы гинекологии, акушерства и перинатологии. 2021;20(2):5–12.</mixed-citation><mixed-citation xml:lang="en">Proklova GF, Sokova EA, Kazakov RE et al. Chilova RA, Zhukova EV, Akopov KO. Polymorphism of the ADRB2 gene as a predictor of preterm birth. Vopr. ginekol. akus. perinatol. (Gynecology, Obstetrics and Perinatology). 2021;20(2):5–12. (In Russ). DOI: 10.20953/1726-1678-2021-2-5-12.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts AK, Monzon-Bordonaba F, Van Deerlin PG et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol. 1999;180(5):1297–1302. DOI: 10.1016/s0002-9378(99)70632-0.</mixed-citation><mixed-citation xml:lang="en">Roberts AK, Monzon-Bordonaba F, Van Deerlin PG et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol. 1999;180(5):1297–1302. DOI: 10.1016/s0002-9378(99)70632-0.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Moore S, Ide M, Randhawa M et al. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG. 2004;111(2):125–132. DOI: 10.1046/ j.1471-0528.2003.00024.x-i1.</mixed-citation><mixed-citation xml:lang="en">Moore S, Ide M, Randhawa M et al. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG. 2004;111(2):125–132. DOI: 10.1046/ j.1471-0528.2003.00024.x-i1.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Anum EA, Hill LD, Pandya A, Strauss JF. Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity. Placenta. 2009;30(3):207–215. DOI: 10.1016/j.placenta.2008.12.007.</mixed-citation><mixed-citation xml:lang="en">Anum EA, Hill LD, Pandya A, Strauss JF. Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity. Placenta. 2009;30(3):207–215. DOI: 10.1016/j.placenta.2008.12.007.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
